Neutropenia

Continuing the Conversation in Myelofibrosis: The Role of Managed Care in Supporting Treatment Goals Through Appropriate Use of Emerging Therapies

Caring for Patients With Chronic Graft-versus-Host Disease: The Important Role of Pharmacists on the Cancer Care Team

Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions

Improving Pharmacists' Knowledge of Endometrial Cancer and Solutions for Equity and Medication Access

New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes and the Role of Oncology Pharmacists

Clinical Updates in AML Induction and Maintenance Regimens and the Role of the Specialty Pharmacist

Managed Care Approaches to Improve Outcomes in Frontline Therapy for Advanced Renal Cell Carcinoma

Demystifying the Details of T-Cell Engaging Bispecific Antibodies: Establishing a Foundation for Oncology Pharmacists

Continuing the Conversation: A Review of Targeted Therapies for Early-Stage Breast Cancer

The Impact of Antibody-Drug Conjugates in Bladder Cancer and Gynecologic Malignancies

Assessing the Role of Antibody-Drug Conjugates in Breast Cancer Treatment Pathways

Opportunities to Optimize Treatment of Non-Small Cell Lung Cancer and Gastric Cancers With Antibody-Drug Conjugates

Exploring the Value of Pharmacist-Led Toxicity Management for New and Emerging Antibody-Drug Conjugates Across Solid Tumors

Improving Patient Outcomes in TNBC: Immunotherapy, PARP, TROP2, Oh My!

A Pharmacologic Overview of Antibody-Drug Conjugates

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

Supporting Safe, Effective, and Equitable Access to B-Cell Maturation Antigen (BCMA)-Directed Treatments in Multiple Myeloma: Strategies for Specialty and Managed Care Pharmac...

Empowering Pharmacists to Improve Care for Patients with Myelofibrosis

Novel Therapeutic Approaches for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer: An Oncology Pharmacy Perspective

Updates and Insights in Managing Anti-Androgen Therapies in Prostate Cancer

Improving Safety and Efficacy of Frontline Treatment Regimens in Advanced Hepatocellular Carcinoma

Exploring the Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma and the Growing Impact of Oncology Pharmacists

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

Optimizing the Utilization of Targeted Therapies in CLL: Considerations and Insights for the Managed Care Professional

Advances in the Treatment of Myelofibrosis: Updates and Considerations for Managed Care Professionals

Improving the Delivery of CAR T-Cell Therapy for Multiple Myeloma

The Challenges of Chemotherapy Drug Shortages: The Oncology Pharmacist’s Perspective and Opportunities for Mitigation

Preparing for the Use of Multi-Cancer Early Detection Tests: Opportunities for Managed Care Professionals to Expand Cancer Screenings and Implement Early Clinical Intervention

Optimizing Safety and Utilization of Targeted Therapies in MET- or RET-Altered Non-Small Cell Lung Cancer

Non-Melanoma Skin Cancers: The Evolution of Treatment With Immune Checkpoint Inhibitors and Its Implications for Oncology Pharmacists